Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
AAV5 Vector for Transducing Brain Cells and Lung Cells
Case ID:
TAB-1175
Web Published:
12/6/2022
The invention described and claimed in this patent application is related to the delivery of heterologous nucleic acids or genes to particular target cells. In particular, the application relates to methods of delivering a heterologous nucleic acid or gene of interest to particular target cells using an Adeno-Associated Virus of serotype 5 (AAV5). The particular target cells identified include the alveolar cells of the lung and cerebellar and ependymal cells of the brain. The methods described herein may be useful in carrying out gene therapy related to diseases of the brain or central nervous system and the respiratory tract.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/AAV5_Vector_for_Transducing_ Brain_Cells_and_Lung_Cells
Keywords:
AAV
AAV5
brain
CB2AXX
CBXXXX
CXXXXX
GB2A2X
GB2XXX
GENE THERAPY
IB4XXX
IBXXXX
IXXXXX
Listed LPM Reichman as of 4/15/2015
LUNG
NB1XXX
NBXXXX
NXXXXX
Post LPM Assignment Set 20150420
Pre LPM working set 20150418
SACGHS DNA Patent Initial Set
USES
Vector
viral vector
Bookmark this page
Download as PDF
For Information, Contact:
John Devany
Technology Transfer Analyst
NIH Technology Transfer
301-594-4090
john.devany@nih.gov